Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial

NCT07371897 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma HNSCC

Interventions

DRUG: Docetaxel and Cisplatin
DRUG: Toripalimab

Sponsor

Sun Yat-sen University